Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2025-04-24 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
独立董事2024年度述职报告（李平）
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度独立董事述职报告（李平）" which translates to the "2024 Annual Independent Director's Work Report (Li Ping)". It is a detailed report by an independent director about their duties, attendance, independence, and activities during the year 2024. The content focuses on governance, director responsibilities, meeting attendance, and compliance with laws and regulations. It does not contain financial statements or audit results, nor is it an announcement of voting results or a regulatory filing. The document is a report on board/management information specifically related to the independent director's role and activities. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2765 characters, which is sufficient for a detailed report but not a full annual report or audit report. No indication of it being a call transcript, earnings release, or other categories is present.
2025-04-24 Chinese
关于使用部分闲置自有资金进行现金管理公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Guangdong Driving Force Biotechnology Group Co., Ltd. regarding the use of part of its idle funds for cash management. It details the purpose, amount, method, duration, decision-making process, risk analysis, and impact of the cash management plan. The document is a formal announcement about financing activities related to the company's capital management, specifically the use of idle funds for investment in low-risk financial products. It is not a full financial report, audit, or earnings release, nor is it a regulatory filing or a report publication announcement. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2025-04-24 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制自我评价报告" which translates to "Internal Control Self-Evaluation Report." It references internal control evaluation standards, regulatory requirements, and detailed internal control assessment results for the fiscal period ending December 31, 2024. The content includes detailed descriptions of internal control systems, governance structures, risk assessments, control activities, and internal audit functions. It also discusses the identification and rectification of internal control deficiencies, both financial and non-financial. The document is comprehensive and contains substantive information about the company's internal control evaluation rather than just an announcement or summary. This type of document aligns with an Audit Report / Information (AR) as it focuses on internal control evaluation and audit-related information, distinct from a full Annual Report (10-K) or other categories. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-24 Chinese
2025年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年第一季度报告" which translates to "2025 First Quarter Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial data for the period ending March 31, 2025. The document explicitly states it is a quarterly report and includes comprehensive financial data and analysis for the quarter. It is unaudited but contains substantive financial information for the quarter, consistent with an Interim / Quarterly Report. There is no indication that this is an announcement or a brief summary; it is the full report itself. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-04-24 Chinese
内部控制审计报告
Regulatory Filings
2025-04-24 Chinese
华兴会计师事务所(特殊普通合伙)关于广东驱动力生物科技集团股份有限公司2024年度募集资金存放与使用情况鉴证报告
Regulatory Filings
2025-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.